NEWS & EVENTS
From Formulation to International Presentation
The introduction of ROSAREM PLLA took place at AMWC Monaco 2026, held from 26–28 March at the Grimaldi Forum in Monte-Carlo. Aesthetic & Anti-Aging Medicine World Congress is the major international meeting for aesthetic and anti-aging medicine, with more than 17,000 professionals from over 140 countries, more than 500 international experts, and over 350 exhibiting companies.
For ReMedium, Monaco provided a fitting setting to introduce ROSAREM PLLA because the product itself reflects the intersection of formulation science, material technology, and modern aesthetic practice. The formulation brings together PLLA (Poly-L-Lactic Acid) and PN (Polynucleotide) alongside Vitamin C, Glutathione, and Sodium Hyaluronate. The combination gives the product a broader formulation profile, bringing together components associated with collagen stimulation, skin regeneration, antioxidant support, and hydration.
A Multi-Component PLLA and PN Formulation Presented to the
International Aesthetic Community
A key part of ROSAREM PLLA is INCUBe™ Technology, which is integrated into the product’s manufacturing process. The technology is designed to protect the active materials throughout production, storage, and distribution while maintaining their intended characteristics.
“Protecting the active materials from production to distribution —
the role INCUBe™ Technology plays throughout the manufacturing process.”
A Global Stage for New Technology
Beyond the product unveiling itself, AMWC Monaco 2026 gave ReMedium a direct line to the international network that ultimately carries innovation like ROSAREM PLLA from the exhibition floor into clinics worldwide. Over the three days of the congress, the ReMedium stand became a meeting point for distributors, regional partners, and members of the aesthetic medicine community — many of them existing collaborators, others new connections formed on-site.
That kind of in-person engagement is central to how a technology-driven launch like this one reaches the physicians who will ultimately use it. ReMedium’s presence at AMWC was as much about strengthening its cooperation network as it was about the product reveal itself — reinforcing relationships with established partners while opening dialogue with new ones interested in bringing ROSAREM PLLA to their markets.
Gallery
